Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

University of Bristol Featured PhD Programmes
Swansea University Featured PhD Programmes
Birkbeck, University of London Featured PhD Programmes
King’s College London Featured PhD Programmes
Max Planck Society Featured PhD Programmes
"stem" AND "cell" AND "th…×
10 miles

stem cell therapy PhD Projects, Programs & Scholarships

We have 34 stem cell therapy PhD Projects, Programs & Scholarships

  • "stem" AND "cell" AND "therapy" ×
  • clear all
Order by 
Showing 1 to 10 of 34
  Generation of high-performance cellular models for neurodegenerative diseases
  Dr Y Choo
Application Deadline: 15 December 2018
Fully-funded industrial PhD studentship in stem cell research for neurodegenerative disease. CONTRACT. Full time employee (Research Student) at Plasticell Ltd.
  Hematopoietic Stem Cell Genetics: Using single cell biology and genetics to understand how hematopoietic stem cells normally sustain blood formation, and how this process is altered during ageing and when leukemia develops.
  Prof Claus Nerlov, Dr P Vyas
Application Deadline: 11 January 2019
Using single cell biology and genetics to understand how hematopoietic stem cells normally sustain blood formation, and how this process is altered during ageing and when leukemia develops.
  How to fix a broken heart - The next frontier: from cell to cage side treatment
  Dr D Connolly, Prof D Werling, Dr J Dudhia
Application Deadline: 10 February 2019
Dilated Cardiomyopathy (DCM) is a common and serious disease, which imposes a significant welfare burden in dogs. DCM is particularly well characterise in Dobermans where a 58.8% cumulative prevalence has been identified in European lines.
  Targeting The Thymus To Improve Immune Recovery Following Stem Cell Transplantation For Cancer Treatment
  Prof G Anderson, Dr W Jenkinson
Applications accepted all year round
Background. The treatment of cancer frequently requires the transplantation of bone marrow to regenerate the immune system that is damaged following ablative therapy.
  Regulation of autophagy in human embryonic stem cells and its therapeutic application in induced pluripotent stem cell-based disease models
  Dr S Sarkar
Applications accepted all year round
Project background. Regulation of proteostasis is critical for maintaining tissue homeostasis. Autophagy, a major intracellular degradation pathway essential for cellular and energy homeostasis, functions in the clearance of aggregation-prone proteins and damaged organelles.
  The effect of polysialyltransferase modulation on tumour cell migration
  Research Group: Institute of Cancer Therapeutics
  Dr S Shnyder, Dr R Falconer
Applications accepted all year round
One of the main reasons for failure of cancer therapy today is an inability to control tumour dissemination, with secondary tumour deposits the cause of morbidity.
  Engineering the skeletal muscle stem cell niche using microporous tissue engineering constructs
  Dr A G Borycki
Application Deadline: 23 January 2019
Background. Satellite cells are skeletal muscle stem cells that reside in a specific micro-environment called the niche and are responsible for muscle repair upon injury or diseases.
  Identifying the role of glycosaminoglycans and microglia in early pathology of mucopolysaccharide diseases
  Dr B BIgger, Dr R Holley, Prof S Flitsch
Applications accepted all year round
Mucopolysaccharidoses (MPS) are inherited metabolic disorders caused by the deficiency of specific lysosomal enzymes required for the catabolism of glycosaminoglycans (GAGs) where each MPS type lacks a specific enzyme resulting in the build-up of GAGs in all cells of the body.
  Carbonic anhydrases as a molecular target to destroy the therapy resistant cancer stem cells in small cell lung cancer (RDF19/HLS/AS/GIELING)
  Dr R Gieling
Application Deadline: 25 January 2019
Cancer treatment is often compromised by populations of cells which are resistant to the therapy. These cells possess stemness properties and are therefore often regarded to be the cancer stem cells (CSCs).
  4 Year Wellcome Trust PhD Programme: Functions & Applications of a Novel Embryonic Stem Cell Signalling Pathway
  Dr GM Findlay
Application Deadline: 14 December 2018
The Findlay lab employs cutting-edge technologies to unravel Embryonic Stem (ES) cell signalling networks (Williams et al, Cell Rep 2016, Fernandez-Alonso et al, EMBO Rep 2017; Bustos et al, Cell Rep 2018), culminating in our recent discovery of the ERK5 pathway as an exciting new regulator of ES cell pluripotency.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2018
All rights reserved.